AU2001246494A1 - Condensed thiazolamines and their use as neuropeptide y5 antagonists - Google Patents
Condensed thiazolamines and their use as neuropeptide y5 antagonistsInfo
- Publication number
- AU2001246494A1 AU2001246494A1 AU2001246494A AU4649401A AU2001246494A1 AU 2001246494 A1 AU2001246494 A1 AU 2001246494A1 AU 2001246494 A AU2001246494 A AU 2001246494A AU 4649401 A AU4649401 A AU 4649401A AU 2001246494 A1 AU2001246494 A1 AU 2001246494A1
- Authority
- AU
- Australia
- Prior art keywords
- thiazolamines
- neuropeptide
- antagonists
- condensed
- condensed thiazolamines
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000003797 Neuropeptides Human genes 0.000 title 1
- 108090000189 Neuropeptides Proteins 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6536—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
- C07F9/6539—Five-membered rings
- C07F9/6541—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
- C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10010475 | 2000-03-03 | ||
| DE10010476 | 2000-03-03 | ||
| DE10010476 | 2000-03-03 | ||
| DE10010475 | 2000-03-03 | ||
| PCT/EP2001/002339 WO2001064675A1 (en) | 2000-03-03 | 2001-03-01 | Condensed thiazolamines and their use as neuropeptide y5 antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001246494A1 true AU2001246494A1 (en) | 2001-09-12 |
Family
ID=26004675
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001246494A Abandoned AU2001246494A1 (en) | 2000-03-03 | 2001-03-01 | Condensed thiazolamines and their use as neuropeptide y5 antagonists |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2001246494A1 (en) |
| WO (1) | WO2001064675A1 (en) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6989379B1 (en) | 1999-04-22 | 2006-01-24 | H. Lundbick A/S | Selective NPY (Y5) antagonists |
| US6340683B1 (en) | 1999-04-22 | 2002-01-22 | Synaptic Pharmaceutical Corporation | Selective NPY (Y5) antagonists (triazines) |
| WO2000064880A1 (en) | 1999-04-22 | 2000-11-02 | Synaptic Pharmaceutical Corporation | Selective npy (y5) antagonists |
| DK1194421T3 (en) * | 1999-06-30 | 2006-02-13 | Lundbeck & Co As H | Selective NPY (Y5) antagonists |
| US7273880B2 (en) | 1999-06-30 | 2007-09-25 | H. Lunbeck A/S | Selective NPY (Y5) antagonists |
| CN100363362C (en) | 2002-02-28 | 2008-01-23 | 霍夫曼-拉罗奇有限公司 | Thiazole derivatives useful as NPY receptor antagonists |
| ES2193875B2 (en) | 2002-04-09 | 2005-03-01 | Laboratorios Del Dr. Esteve, S.A. | DERIVATIVES OF BENZOXAZINONA, ITS PREPARATION AND ITS APPLICATION AS MEDICATIONS. |
| CN100381429C (en) * | 2002-08-07 | 2008-04-16 | 霍夫曼-拉罗奇有限公司 | Thiazole derivatives |
| BRPI0413458A (en) | 2003-08-12 | 2006-10-17 | Hoffmann La Roche | compounds, process for their preparation, pharmaceutical composition comprising them, use of a compound, methods for the treatment and prophylaxis of arthritis, diabetes, eating disorders and obesity |
| RU2506267C2 (en) | 2008-03-31 | 2014-02-10 | Дженентек, Инк. | Benzopyrazine and benzoxepine pi3k inhibitors and use thereof |
| EP2404902A1 (en) | 2009-03-05 | 2012-01-11 | Shionogi&Co., Ltd. | Piperidine and pyrrolidine derivatives having npy y5 receptor antagonism |
| AU2010299820A1 (en) * | 2009-09-28 | 2012-04-19 | F. Hoffmann-La Roche Ag | Benzoxepin PI3K inhibitor compounds and methods of use |
| ES2444779T3 (en) | 2009-09-28 | 2014-02-26 | F. Hoffmann-La Roche Ag | Benzoxazepine compounds PI3K inhibitors and their use in cancer treatment |
| RU2013143747A (en) | 2011-03-21 | 2015-04-27 | Ф. Хоффманн-Ля Рош Аг | BENZOXAZEPINE COMPOUNDS SELECTIVE FOR PI3K P110 DELTA AND METHODS OF APPLICATION |
| AR089999A1 (en) | 2012-02-17 | 2014-10-01 | Hoffmann La Roche | TRICYCLE COMPOUNDS AND METHODS FOR THE USE OF THE SAME |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19824175A1 (en) * | 1998-05-29 | 1999-12-02 | Novartis Ag | Amino azole compounds |
| DE19908537A1 (en) * | 1999-02-26 | 2000-08-31 | Aventis Pharma Gmbh | Use of polycyclic 2-amino-thiazole systems for the preparation of medicaments for the prophylaxis or treatment of obesity |
| DK1194421T3 (en) * | 1999-06-30 | 2006-02-13 | Lundbeck & Co As H | Selective NPY (Y5) antagonists |
-
2001
- 2001-03-01 AU AU2001246494A patent/AU2001246494A1/en not_active Abandoned
- 2001-03-01 WO PCT/EP2001/002339 patent/WO2001064675A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001064675A1 (en) | 2001-09-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI316062B (en) | Anti-inflammatory compounds and uses thereof | |
| AU2001294547A1 (en) | Substituted urea neuropeptide y y5 receptor antagonists | |
| HUP0500880A2 (en) | Cxcr3 antagonists and pharmaceutical compositions thereof | |
| HUP0301201A3 (en) | Methods and compositions utilizing quinazolinones | |
| AU2001294814A1 (en) | Pumpcn compositions and uses thereof | |
| IL138471A0 (en) | Novel semiconductor materials and their uses | |
| AU2002235224A1 (en) | Muscarinic antagonists | |
| IL152700A0 (en) | Substituted 1-aminoalkyl-lactams and their use as muscarinc receptor antagonists | |
| IL156161A0 (en) | Substituted 2-anilino-benzimidazoles and the use thereof as nhe-inhibitors | |
| AU2001240637A1 (en) | Novel imidazotriazinones and the use thereof | |
| AU2001246494A1 (en) | Condensed thiazolamines and their use as neuropeptide y5 antagonists | |
| GB0101035D0 (en) | Formulation and use thereof | |
| AU2001234741A1 (en) | Integrin antagonists | |
| GB0026467D0 (en) | Compound, composition and use | |
| SG100745A1 (en) | Ceramic composition and ceramic capacitor | |
| AU2001276461A1 (en) | Cleaning compositions and their use | |
| HUP0401535A3 (en) | Somatostatin antagonists and their use | |
| HUP0300050A3 (en) | Detergent composition and its use | |
| HUP0303936A3 (en) | Novel composition and use | |
| AU2001276258A1 (en) | Ceramic component and the use thereof | |
| GB2379320B (en) | Street furniture or the like | |
| GB0007530D0 (en) | Trityl-type compounds and their use | |
| GB0021497D0 (en) | Compounds and their use | |
| AU2002224825A1 (en) | Substituted amidoalkyl uracils and the use thereof | |
| GB0005301D0 (en) | Compound, composition and use |